Insights+: COVID-19 Healthcare News Monthly Updates – December 2020

 Insights+: COVID-19 Healthcare News Monthly Updates – December 2020

Insights+: COVID-19 Healthcare News Monthly Updates – December 2020

  • Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
  • Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
  • PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date

01. NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100 for Critical COVID-19 with Respiratory Failure

Dec 29, 2020 | Clinical Trial

02. Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

Dec 29, 2020 | Regulatory

03. Introducing COMIRNATY, the EU Brand Name for Pfizer & BioNTech’s COVID-19 Vaccine, Developed by Brand Institute

Dec 28, 2020 | Regulatory

04. INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet’s EClinicalMedicine

Dec 24, 2020 | Collaboration

05. Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

Dec 24, 2020 | Collaboration

06. Providence Therapeutics COVID-19 Vaccine Receives Health Canada Authorization to Begin Clinical Trials

Dec 23, 2020 | Regulatory

07. Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine

Dec 23, 2020 | Clinical Trial

08. Infor and MphRx Announce Global Solution to Help Healthcare Organizations Manage COVID-19 Vaccine Inoculation with Real-World Clinical Data

Dec 22, 2020 | Clinical Trial

09. eTrueNorth Enabling Patient Recruitment in Clinical Trial to Accelerate the Use of Wearable Diagnostics for Early Identification and Containment of COVID-19

Dec 22, 2020 | Clinical Trial

10. RedHill’s Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue

Dec 22, 2020 | Clinical Trial

11. RDIF, The Gamaleya National Center, AstraZeneca and R-Pharm sign an Agreement to Cooperate on COVID-19 Vaccine Development

Dec 21, 2020 | Collaboration

12. Principle LTC’s Tower Nursing & Rehabilitation Center Joins with Eli Lilly and Company on Phase 3 Drug Trial for COVID-19 Prevention

Dec 21, 2020 | Clinical Trial

13. Positive Results Show that C21 can Become an Important Complement to COVID-19 Vaccines

Dec 21, 2020 | Clinical Trial

14. ImmuneMed’s hzVSF-v13, COVID-19 Clinical Trials Accelerate Development of the Treatment

Dec 20, 2020 | Clinical Trial

15. Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the U. S. FDA EUA Published in New England Journal of Medicine

Dec 19, 2020 | Clinical Trial

16. Lilly to Begin Pragmatic Study of Neutralizing Antibody Bamlanivimab (LY-CoV555) for COVID-19 in New Mexico

Dec 18, 2020 | Clinical Trial

17. Stroke and Altered Mental State Increase Risk of Death for COVID-19 Patients

Dec 18, 2020 | Clinical Trial

18. Beckman Coulter Launches One of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.

Dec 18, 2020 | Regulatory

19. Research on Preventative Nasal Spray, Which Protects Against COVID-19 and Common Cold, Published in Leading Peer-Reviewed Academic Journals

Dec 17, 2020 | Clinical Trial

20. New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

Dec 17, 2020 | Clinical Trial

21. Circuit Clinical And The Center for Integrated Global Biomedical Sciences At The University at Buffalo Join Efforts In Regional And Global COVID-19 Clinical Research

Dec 17, 2020 | Collaboration

22. Pathology Lab and Health Information Exchange Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Dec 17, 2020 | Collaboration

23. Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion

Dec 17, 2020 | Clinical Trial

24. Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe

Dec 17, 2020 | Regulatory

25. BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials

Dec 16, 2020 | Clinical Trial

26. International, Federal, State and Local Agencies Choose Salesforce to Help Manage their COVID-19 Vaccine Efforts

Dec 16, 2020 | Regulatory

27. Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

Dec 15, 2020 | Regulatory

28. RedHill’s Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model

Dec 15, 2020 | Clinical Trial

29. Muscular Dystrophy Association Releases FAQs for the Neuromuscular Disease Community for Access to the COVID-19 Vaccines

Dec 15, 2020 | Regulatory

30. Medela Announces New Data Demonstrating that Thopaz+ Digital Chest Drain Improves Safety and Helps Prevent Cross-Contamination During the COVID-19 Pandemic and Beyond

Dec 15, 2020 | Clinical Trial

31. Binx Health Receives EUA Authorizing At-Home COVID-19 Sample Collection by Universities and Employers

Dec 15, 2020 | Regulatory

32. Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Dec 14, 2020 | Collaboration

33. Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

Dec 14, 2020 | Clinical Trial

34. Emmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19

Dec 14, 2020 | Clinical Trial

35. HLS Therapeutics Reports Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with Vascepa (Icosapent Ethyl)

Dec 14, 2020 | Clinical Trial

36. Pharmacy Organizations Welcome FDA Authorization of COVID Vaccine: “We Stand Ready to Serve”

Dec 11, 2020 | Regulatory

37. Kintor Proxalutamide’s COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates

Dec 11, 2020 | Clinical Trial

38. Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine

Dec 11, 2020 | Clinical Trial

39. ADEXUSDx COVID-19 Antibody Test Filed for Point of Care Emergency Use Authorization

Dec 10, 2020 | Regulatory

40. INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China

Dec 10, 2020 | Clinical Trial

41. The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19

Dec 10, 2020 | Clinical Trial

42. Pharming Announces Enrolment of First Patient in US Clinical Trial for the Treatment of COVID-19 with RUCONEST

Dec 10, 2020 | Clinical Trial

43. Cyxone Receives Regulatory Approval to Initiate a Clinical Phase 2 Study with Rabeximod in Covid-19 patients

Dec 08, 2020 | Regulatory

44. NorthShore Joins Fight Against COVID-19 with Convalescent Plasma Trials for Close Contact Exposed and Newly Diagnosed Patients

Dec 08, 2020 | Clinical Trial

45. Vicore Pharma Reports Positive Top Line Data from the ATTRACT Clinical Study in Patients with COVID-19

Dec 08, 2020 | Clinical Trial

46. Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test

Dec 07, 2020 | Collaboration

47. INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

Dec 07, 2020 | Clinical Trial

48. NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100 for Critical COVID-19 with Respiratory Failure

Dec 07, 2020 | Clinical Trial

49. Hematologists Play Vital Role in Advancing COVID-19 Research, Potential Treatments

Dec 05, 2020 | Clinical Trial

50. New CRISPR-Based Test for COVID-19 Uses a Smartphone Camera

Dec 04, 2020 | Regulatory

51. Lilly and UnitedHealth Group Partner on Pragmatic Study of Neutralizing Antibody Bamlanivimab (LY-CoV555) for COVID-19

Dec 04, 2020 | Collaboration

52. Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19

Dec 03, 2020 | Clinical Trial

53. Ixlayer and CIC Health Partner to Make COVID-19 Tests More Accessible to School Districts and Universities

Dec 03, 2020 | Collaboration

54. Drawbridge Health Partners with University of Cambridge Researchers for Use of OneDraw Blood Collection Device in COVID-19 and Other Clinical Studies

Dec 03, 2020 | Collaboration

55. Made-in-Canada COVID Testing Now Available: LuminUltra Receives Health Canada Authorization for Rapid, Portable COVID-19 qPCR Testing Solutions

Dec 03, 2020 | Regulatory

56. INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.

Dec 03, 2020 | Regulatory

57. Octapharma USA Presents Results of Investigational Use of Octagam 10% for Severe COVID-19 Patients at ASH Annual Meeting

Dec 02, 2020 | Clinical Trial

58. Ampio’s Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress

Dec 02, 2020 | Clinical Trial

59. European Based Rapid PCR-COVID19 Home-Test Company Selfdiagnostics is toSubmit Request for Authorisation

Dec 02, 2020 | Regulatory

60. Celularity Announces Positive DMC Safety Review and Continuation of its Phase I/II CYNK-001-COVID-19 (CYNKCOVID) Study

Dec 01, 2020 | Clinical Trial

61. World’s Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19

Nov 30, 2020 | Clinical Trial

62. Harvard’s Wyss Institute Licenses its eRapid Technology to The iQ Group Global to Accelerate the Development of COVID-19 Diagnostics

Nov 30, 2020 | Regulatory

63. LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

Nov 30, 2020 | Collaboration

64. Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

Nov 30, 2020 | Clinical Trial

Related Post:-  Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post